PDGFRB and neoplasm: This finding aligns with established roles of PDGFRB in promoting angiogenesis and stromal activation through platelet-derived growth factor signaling (21), while CST4’s cysteine protease inhibitory function likely stabilizes the tumor microenvironment by preventing excessive ECM degradation (22).